Page last updated: 2024-10-29

ketanserin and Death, Sudden

ketanserin has been researched along with Death, Sudden in 1 studies

Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.

Death, Sudden: The abrupt cessation of all vital bodily functions, manifested by the permanent loss of total cerebral, respiratory, and cardiovascular functions.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kirkendall, WM1

Other Studies

1 other study available for ketanserin and Death, Sudden

ArticleYear
Prolonged QTc, thiazides, and sudden death.
    Archives of internal medicine, 1991, Volume: 151, Issue:2

    Topics: Death, Sudden; Diuretics; Drug Interactions; Electrocardiography; Humans; Ketanserin

1991